Methyla-D-laminarabioside

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Methyla-D-laminarabioside
• 英文别名: 2-[3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
• 化学式: C₁₃H₂₄O₁₁
• 分子量: 356.32
• InChiKey: WOKXHOIRHHAHDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.6
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  179
• 氢给体数：
  7
• 氢受体数：
  11

文献信息

• DENDRIMERS WITH A SACCHARIDE ENDING FOR ANTI-INFLAMMATORY PURPOSES
  申请人：Prandi Jacques

  公开号：US20130274210A1

  公开（公告）日：2013-10-17

  The present invention relates to dendrimers with a monosaccharide, oligosaccharide or polysaccharide terminal group, to their preparation method and their therapeutic uses, notably anti-inflammatory uses.

  本发明涉及具有单糖、寡糖或多糖末端基团的树状分子，其制备方法以及它们的治疗用途，特别是抗炎用途。
• Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
  申请人：Wang Tianxin

  公开号：US20170165334A1

  公开（公告）日：2017-06-15

  The current invention discloses methods to modify protein and peptide and antigen to treat disease such as pathogen infection, autoimmune diseases and cancer. The method involves increasing the molecular weight of the protein by connecting multiple peptide units with site specific conjugation to extend the in vivo half life. The current invention also discloses methods to construct activatable enzyme, which becomes active when they reach the treatment target, therefore provide higher specificity for treatment. The current invention also relates to methods to treat disease with hemopurification.